Comparative Efficacy and Safety of Individual SGLT2 Inhibitors (Dapagliflozin, Empagliflozin, and Canagliflozin) on Kidney Function Decline in CKD: A Systematic Review and Network Meta-Analysis. OAIJMR 2025, 5 (6), 1772-1789. https://doi.org/10.37275/oaijmr.v5i6.818.